ACTRN12614000455662已完成未知
Evaluation of the Outcomes of Renal functions and Urinary neutrophil gelatinase-associated lipocalin (NGAL) excretion in Mild Maternal Hydronephrosis and normal pregnancies
Emre Goksan Pabuccu0 个研究点目标入组 86 人开始时间: 2014年5月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 86
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 40 Years（—）
- 性别
- Female
入选标准
- •singleton pregnancies between 24-36 weeks of gestation without identifiable maternal and fetal disorders other than maternal hydronephrosis.
排除标准
- •-Active urinary tract infection
- •-urolithiasis
- •-known genitourinary anomalies
- •-gestational or nongestational diabetes mellitus
- •-preeclampsia
- •-chronic hypertension
- •-chronic kidney or liver diseases
- •-chronic vascular or connective tissue diseases
- •The well-being of the fetus and the pregnancy was
- •established with a biophysical profile scoring. Pregnancies
- •with a jeopardized fetus, Bishop score over four, or active
- •labor were excluded.
研究者
相似试验
进行中（未招募）
1 期
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851EUCTR2014-005033-31-FRAddmedica S.A.S
已完成
不适用
Prospective evaluation of renal function and proteinuria in chronic kidney disease patientsProteinuriaJPRN-UMIN000007371Aichi welfare agricultural cooperative association Anjo Kosei Hospital60
已完成
不适用
Influence of renal dysfunction on the outcomes of hepatectomy for hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000041749Hiroshima University238
进行中（未招募）
1 期
A study to assess the renal function in young male patients with Fabry disease who have never received any specific treatment for this disease.Fabry diseaseMedDRA version: 15.0Level: PTClassification code 10016016Term: Fabry's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2012-001966-14-ESGenzyme, a Sanofi Company39
撤回
4 期
A Cross-sectional Study of Renal Function in Treatment-naïve, Young Male Patients with Fabry Diseaseinherited enzyme deficiencymetabolic disorder1008362410021605NL-OMON39057Sanofi-aventis3